We chose to examine the tyrosination/detyrosination cycle as a potential driver of α-tubulin acetylation because we recently showed a decrease of TTL and an increase in detyrosinated and Δ2 tubulin levels in sporadic and familial forms of AD. Here, TTL is linked to Alzheimer disease.